Sun Pharma Sets Q1 Earnings Call for July 31 After 34% Profit Jump in Q4
Sun Pharma will discuss its Q1 FY27 financial performance on July 31. The focus remains on specialty drug growth and regulatory compliance at domestic manufacturing sites.
Read the full articleYou might also wanna read
Pharma companies' Q1 margins likely to decline despite revenue growth: Goldman Sachs
New Delhi [India], July 9 (ANI): Indian pharmaceutical companies are expected to report improved revenues in the first quarter of FY2026-27,
Indian Pharma Q1FY27: Revenue up, but profits to dip, says report
Indian pharma firms are set for improved Q1FY27 revenues, but a Goldman Sachs report warns of declining margins. This is due to an unfavorab
Pharming Group to report second quarter and first half 2026 financial results and provide business update on July 30
Leiden, the Netherlands, July 16, 2026: Pharming Group N.V. ("Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will repo
Stocks Priced for ‘Sunshine and Rainbows’ Now Face Earnings Test
Wall Street is anticipating a near-record earnings season, but for investors a key question remains: Will it be enough to keep stock market
Sunrun Announces Date for First Quarter 2026 Earnings Report
Procter & Gamble Earnings Are Coming July 29. The Trough Quarter May Already Be Priced In.
Procter & Gamble stock looks priced for the trough. TIKR’s model says the recovery is already scheduled.
Comments
Sign in to join the conversation.
No comments yet. Be the first.